IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q1 2015 Holdings

Filed 2015-04-29 | 4 holdings | $937.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Sage Therapeutics, Inc.(SG7)COM78667J108$490.9K9,773,07352.4%
Foundation Medicine, Inc.COM350465100$237.0K4,927,23425.3%
Zafgen Inc.COM98885E103$166.4K4,202,04517.8%
Eleven Biotherapeutics, Inc.COM286221106$43.2K4,841,5914.6%